Novartis

(NYSE:NVS)
  Jun 30, 2008 Mar 31, 2008 Dec 31, 2007 Sep 30, 2007
Cash Flow Statement
Cash At Beginning Of Period 5,360,000 5,360,000 3,815,000 3,815,000
Cash At End Of Period 14,069,000 6,931,000 5,360,000 7,414,000
Net Change In Cash And Cash Equivalents 8,709,000 1,571,000 1,545,000 3,599,000
Effect Of Exchange Rate Changes 124,000 86,000 298,000 97,000
Net Income Or Loss 4,574,000 2,308,000 6,540,000 5,609,000
Cash From Operating Activities
Depreciation Expenses 1,258,000 634,000 2,073,000
Amortization Expenses
Amortization Of Intangibles Expenses
Deferred Income Taxes 746,000
Operating Gains Or Losses -199,000 116,000 -1,297,000 -1,136,000
Extraordinary Gains Or Losses
Increase Or Decrease In Receivables -204,000
Increase Or Decrease In Inventories -747,000
Increase Or Decrease In Prepaid Expenses
Increase Or Decrease In Other Current Assets
Increase Or Decrease In Payables -1,320,000
Increase Or Decrease In Other Current Liabilities 323,000
Increase Or Decrease In Other Working Capital
Other Non Cash Items -1,839,000 93,000
Net Cash From Continuing Operations -999,000 -1,369,000 4,502,000 1,021,000
Net Cash From Discontinued Operations 3,541,000 1,689,000 9,210,000 6,247,000
Net Cash From Operating Activities 69,000 51,000 7,599,000 7,980,000
Cash From Investing Activities
Sale Of Property Plant And Equipment 241,000
Sale Of Long Term Investments
Sale Of Short Term Investments
Purchase Of Property Plant And Equipment -967,000 -403,000 -3,133,000 -1,795,000
Acquisitions -52,000 -52,000
Purchase Of Long Term Investments
Purchase Of Short Term Investments -7,232,000 -2,716,000
Other Investing Changes Net 31,000
Cash From Discontinued Investing Activities
Net Cash From Investing Activities 4,485,000 3,434,000 -6,244,000 -4,563,000
Cash From Financing Activities
Issuance Of Debt 1,849,000
Issuance Of Capital Stock -2,170,000
Repayment Of Debt -532,000 -6,448,000
Repurchase Of Capital Stock -3,345,000 -2,598,000
Payment Of Cash Dividends -3,689,000 38,000 -6,162,000
Net Other Financing Charges -3,689,000 38,000 -6,162,000
Cash From Discontinued Financing Activities
Net Cash From Financing Activities 490,000 -3,689,000 -9,318,000 -6,162,000